Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Sampre Nutritions Ltd (NSE: SAMPRE), ISIN INE375C01022 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
SAMPRE last traded at ₹6.05 (+0.83%), with a 52-week range of ₹4.51 to ₹42.33 (as of 23 Sep 2026).
Shareholding as of Dec 2025: promoters 15.26%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 62/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.